Renal and systemic effects of synthetic atrial natriuretic factor.
A synthetic peptide corresponding to a sequence of 26 amino acids contained in endogenous rat atrial natriuretic factor (ANF), was infused into one renal artery of anesthetized dogs for a comprehensive in vivo evaluation of the renal and systemic effects of pure ANF. The results proved conclusively that ANF acted directly on the kidney since urine volume and fractional excretion of sodium, potassium, chloride and calcium were elevated in a dose-related manner in the ANF-treated kidney, but were not significantly affected in the contralateral saline-infused organ. The maximum effects achieved with the synthetic ANF were higher than any reported following intravenous administration of crude extracts of rat atria and were similar to those produced by thiazide diuretics. In four of the five dogs studied, renal vascular resistance fell progressively as doses of ANF were increased. Glomerular filtration rate was not significantly elevated during ANF infusion, but was correlated with sodium excretion rates. Even though mean arterial pressure was progressively reduced, there was no significant change in heart rate and no stimulation of renin secretion. Arterial cyclic GMP concentration was higher in the basal state and rose more rapidly than did renal venous levels, indicating that increases in circulating concentrations of arterial cyclic GMP originated from an extrarenal source. Dose-related elevations in urinary cyclic GMP excretion could be explained by increased cyclic GMP filtration, by enhanced production in tubular cells, or by renal tubular secretion. Especially in the saline-infused kidney, there was a clear dissociation between excretion of cyclic GMP and fractional sodium excretion. We conclude that the synthetic ANF increased electrolyte excretion via a direct renal action which was not solely dependent upon changes in renal vasculature, renin secretion or cyclic GMP levels.
Seymour
A A
AA
Blaine
E H
EH
Mazack
E K
EK
Smith
S G
SG
Stabilito
I I
II
Haley
A B
AB
Napier
M A
MA
Whinnery
M A
MA
Nutt
R F
RF
D000818:Animals; D009320:Atrial Natriuretic Factor; D000242:Cyclic AMP / Q000097:blood / Q000652:urine; D006152:Cyclic GMP / Q000097:blood / Q000652:urine; D004285:Dogs; D005260:Female; D007668:Kidney / Q000187:drug effects / Q000502:physiology*; D007700:Kinetics; D009318:Natriuresis / Q000187:drug effects*; D010446:Peptide Fragments; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D012079:Renal Circulation / Q000187:drug effects; D012083:Renin / Q000378:metabolism; D014655:Vascular Resistance / Q000187:drug effects
D010446:Peptide Fragments; D010455:Peptides; D009320:Atrial Natriuretic Factor; C043970:atrial natriuretic factor 26, rat; D000242:Cyclic AMP; D012083:Renin; D006152:Cyclic GMP